<?xml version="1.0" encoding="UTF-8"?>
<p id="para190">On completion of study treatment, patients with a complete response or unconfirmed complete response could proceed to high-dose chemotherapy and autologous stem-cell transplantation at the local investigator's discretion. Consolidation radiotherapy to sites of initial bulk or residual disease was also permitted at the end of treatment at the investigator's discretion.</p>
